ILS: ILS Expands Predictive Tools for Biotech

Integrated research services that combine genomics and traditional methodologies are the focus of ILS-or Integrated Laboratory Systems-a full-service CRO in Research Triangle Park, NC."We can develop and validate novel single nucleotide polymorphism (SNP) assays and the biological data that supports the use of that SNP. That combination sets us apart," says Leslie Recio, Ph.D., DABT, chief scientist at ILS. These SNP capabilities are being honed in a project supported by the National Cancer Institute. The goal of the project is to develop and validate an SNP assay and to assess the impact of this SNP on the efficacy of a cancer chemotherapeutic agent."We understood the toxicology," asserts Dr. Recio. "We knew the types of biological data that were needed to support this SNP before it could move to clinical trials." And so ILS was well positioned to win the grant.